[Dermatological evaluation of amikacin (BB-K8) (author's transl)].
D000038:Abscess / Q000188:drug therapy; D000368:Aged; D000818:Animals; D005153:Facial Neoplasms / Q000601:surgery; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D051381:Rats; D012867:Skin / Q000378:metabolism; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects; D013530:Surgical Wound Infection / Q000188:drug therapy
D007612:Kanamycin